Eye care in Australia and New Zealand is poised to enter a new era with the launch of ZEISS Cirrus PathFinder. Cirrus PathFinder is a fully integrated, artificial intelligence-based support tool that enhances decision-making confidence by assisting with optical coherence tomography (OCT) interpretation. Designed to complement clinical workflows, it streamlines the review of macular OCT scans by automatically identifying scans that may require closer examination.
Cirrus PathFinder employs state-of-the-art deep learning algorithms, trained on over 75,000 OCT B-scan images, to automatically flag abnormalities in macular scans. From subretinal fluid (SRF) to retinal pigment epithelium (RPE) atrophy, PathFinder helps pinpoint subtle changes that could indicate early signs of disease.
Cirrus PathFinder employs state-of-the-art deep learning algorithms… to automatically flag abnormalities in macular scans
Why Use Cirrus PathFinder?
- Supports smarter diagnoses, faster: By flagging scans of interest, PathFinder can support clinicians in detecting retinal abnormalities.
- Streamlines workflows: Integrated directly into the Cirrus platform,* PathFinder eliminates the need for third-party tools.
- High confidence: Validated through peer-reviewed research and developed in collaboration with leading retinal specialists, PathFinder has been shown to deliver 88% sensitivity and 93% specificity.1
For more information at ZEISS Cirrus PathFinder.
*Available in August for ZEISS CIRRUS 6000 devices with the planned release for ZEISS CIRRUS 500 and 5000 devices in the coming months.
Reference
- Talcott KE, Valentim CCS, Singh RP, et al. Automated detection of abnormal optical coherence tomography b-scans using a deep learning artificial intelligence neural network platform. Int Ophthalmol Clin. 2024 Jan 1;64(1):115-127. doi: 10.1097/IIO.0000000000000519.
